Delivery Order SPE2DB20D3103-SPE2DB25FN5F8

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,441.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,155,189 units of Doxycycline Mono 100 mg capsules. The award is a firm-fixed-price delivery order with a completion date of February 5, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,386.76 Firm Fixed Price delivery order is for the supply of 4,568,173,914 units of Doxycycline Mono 100 mg capsules. The contract has a period of performance through May 8, 2025 and was awarded on May 7, 2025. No set-aside designation is mentioned, indicating this was an open competition. AmerisourceBergen holds a...
This federal contract award, valued at $1,905.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,558,461,377 units of Doxycycline Mono 100 mg capsules, a generic antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 15, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.28 firm fixed-price delivery order is for the supply of 4,567,482,567 Doxycycline Mono 100 mg tablets in 250-count bottles. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,420.51 firm fixed-price delivery order is for the supply of 4,564,544 units of doxycycline monohydrate 100 mg capsules. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,015.82 Firm Fixed Price Delivery Order contract is for the supply of 4,566,249 units of Doxycycline Mono 100 mg tablets. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,173,863 units of doxycycline monohydrate 100 mg capsules. The $4,487.10 firm fixed-price delivery order has a performance period through May 8, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,619,033 units of Doxycycline Hyclate 100 mg capsules. The fixed-price delivery order, valued at $1,350.96, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,511,468 units of Doxycycline 100mg in 1,000 count containers. The $3,365.38 firm fixed-price Delivery Order contract has a completion date of December 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,283.49 firm fixed-price delivery order is for the supply of 4,566,178,214 units of doxycycline hyclate 100 mg capsules. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN5F8
    Delivery Order

This federal contract award, valued at $2,149.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,990 units of Doxycycline Mono 100 mg capsules in 250-count packages. It is a firm-fixed-price delivery order with an ultimate completion date of April 23, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award does not mention any set-aside designation, indicating open competition.

Generated 7/22/25, 9:48 AM